Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome-Reference-Cited by-同舟云学术

Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome

Published:2013-01-23 Issue:6 Volume:28 Page:911-918
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Tellier Stéphanie,Brochard Karine,Garnier Arnaud,Bandin Flavio,Llanas Brigitte,Guigonis Vincent,Cailliez Mathilde,Pietrement Christine,Dunand Olivier,Nathanson Sylvie,Bertholet-Thomas Aurélia,Ichay Lydia,Decramer Stéphane

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00467-012-2406-3.pdf

Reference33 articles.

1. Haffner D, Fischer DC (2009) Nephrotic syndrome and rituximab: facts and perspectives. Pediatr Nephrol 24:1433–1438

2. Hodson EM, Alexander SI (2008) Evaluation and management of steroid-sensitive nephrotic syndrome. Curr Opin Pediatr 20:145–150

3. Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F (2008) Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 23:1269–1279

4. Sellier-Leclerc AL, Macher MA, Loirat C, Guerin V, Watier H, Peuchmaur M, Baudouin V, Deschenes G (2010) Rituximab efficiency in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 25:1109–1115

5. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou JP (1994) Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. New Eng J Med 330:7–14

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of long-term repeated use of rituximab in pediatric patients with nephrotic syndrome;Pediatric Nephrology;2023-09-08

2. Rituximab with tacrolimus for relapsing diffuse podocytopathy in adulthood: A therapeutic option;Clinical Nephrology;2023-08-01

3. Efficacy and safety of long-term repeated use of rituximab in pediatric patients with nephrotic syndrome;2023-05-17

4. Prophylactic rituximab administration in children with complicated nephrotic syndrome;Pediatric Nephrology;2020-09-30

5. The efficacy of rituximab in the treatment of refractory nephrotic syndrome: a meta-analysis;International Urology and Nephrology;2020-04-15